| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 34 |
| 1 | ASPIRIN | 18 |
| 2 | ASPIRIN 325 MG | 18 |
| 3 | ASPIRIN 81 MG | 18 |
| 4 | FUROSEMIDE | 12 |
| 5 | OMEPRAZOLE MAGNESIUM | 12 |
| 6 | METHOTREXATE | 11 |
| 7 | LISINOPRIL | 10 |
| 8 | METHOTREXATE SODIUM | 10 |
| 9 | ATORVASTATIN CALCIUM | 9 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 1 | Corticosteroid [EPC] | 19 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 18 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 4 | Proton Pump Inhibitor [EPC] | 14 |
| 5 | Benzodiazepine [EPC] | 13 |
| 6 | Loop Diuretic [EPC] | 13 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 8 | Osmotic Laxative [EPC] | 12 |
| 9 | Platinum-based Drug [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Non-Standardized Plant Allergenic Extract [EPC] | 4 | 0.0002 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |
| 7 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 8 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 9 | Cardiac Glycoside [EPC] | 9 | 0.0001 |